Clinical Trial Update: Ivonescimab for the Treatment of Thymic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Ivonescimab for thymic carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Thymus Carcinoma | Phase 2 | Status: RECRUITING